- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05638191
Nerve Transfer Surgery to Restore Upper-limb Function After Cervical Spinal Cord Injury
Nerve Transfer Surgery to Restore Upper-limb Function After Ceervical Spinal Cord Injury
Study Overview
Status
Detailed Description
The purposes of this study are:
- To quantify functional and motor outcomes of NT in patients with SCI, using robust outcome measures, rigorous pre-operative clinical and neurophysiological assessments, and standardized rehabilitation, and to compare these outcomes against individuals who did not undergo nerve transfer surgery.
- To develop a model for predicting NT outcomes using pre-operative clinical and neurophysiological characteristics.
Outcome measures:
Purpose 1: The primary study outcome is the Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP Ver. 1). Secondary outcomes are the Spinal Cord Independence Measure (SCIM) and motor outcomes in recipient muscles following NT, including muscle strength and neurophysiological assessments at 3 months intervals post-operatively, to final outcome measurement at 24 months.
Purpose 2: Relevant demographic, clinical variables and neurophysiological variables (including joint range of motion, muscle spasticity, pain, depression motor unit number estimation in recipient muscles and ultrasound evaluation of recipient muscle quality), are a priori variables that will be collected at baseline, in order to develop a clinical prediction tool to inform prognosis.
Research Design:
All SCI individuals referred to an interdisciplinary clinic for potential nerve transfer will undergo a standardized clinical examination, according to the International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI), to classify neurological level of injury. As well, electrodiagnostic test which will be performed by one of our highly qualified physicians. Individuals who are deemed candidates for nerve transfer surgery will be screened and invited to participate in the study. Participation in the study will not, in any way, influence clinical care.
After receiving written consent, outcome measurement will take place pre-operatively, then at 3-month intervals post operatively; final analysis will occur at 24 months after surgery. As well, a control group consisting of those SCI individuals who chose to not undergo or are not candidates for surgery will be recruited. This "control group" will undergo assessments at 24 months following their injuries, in line with the anticipated functional plateau in spontaneous recovery expected . Outcome measurement will be performed at GF Strong Rehabilitation Hospital (Primary site), the International Collaboration on Repair Discoveries (ICORD), Sunnybrook Hospital in Toronto, and Kingston Health Science Centre. Rehabilitation will be administered by highly qualified hand therapists with standardized frequency, and duration for all individuals. All study data will be stored in a REDCap database which will be shared between all participating institutions.
Outcome measurement & information collected include:
Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP), which is a validated upper limb functional measure, specifically designed for use in SCI (Kalsi-Ryan et al. 2012). It incorporates three domains vital to upper limb function: sensation, strength, and prehension. It is a multimodal test comprising 5 subtests for each upper limb: dorsal sensation, palmar sensation, strength, prehension ability and prehension performance. The GRASSP results in 5 numerical scores that provide a comprehensive profile of upper-limb function and will be administered by GRASSP certified research personnel. As well, individuals will be asked to complete the Spinal Cord Independence Measure (SCIM) questionnaire (Catz A, et al. 1997) on the same day of their visit.
At Baseline, a validated technique called motor unit number estimation (MUNE) counts the number of MN's and can be essential in evaluating MN health. We aim to carry out this technique towards measuring the health of MN's in functionally relevant muscles in patients with SCI and comparing this with healthy controls. The purpose of this study is to provide a quantitative measure of the size of MN pool in clinically relevant muscles below the level of SCI using MPS and MScan MUNE. We will also supplement information about MNs with ultrasound-derived measures of muscle quality.
Ultrasound sonography recording will be taken to analyze the structural health of recipient muscles and to quantify muscle fibrosis and atrophy. The muscles of interest will be anatomically identified and marked, and ultrasound gel will be applied to skin surface of the upper limb prior to placing the ultrasound probe. Individuals will be asked to lie in a dimly lit room for this portion of the study.
Demographic information will be collected for each participant, including
- age;
- sex;
- medical comorbidities; and
- medications
Clinical factors influencing functional and motor recovery in SCI will be measured:
- spasticity with modified Ashworth scores;
- depression with Beck's depression inventory (Beck, A. T., et al. 1996);
- passive ranges of motion in joints targeted by NT; and
- brief pain inventory (Ullrich PM, et al. 2008).
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Michael Berger, MD, PhD
- Phone Number: 778-990-7615
- Email: michael.berger@vch.ca
Study Locations
-
-
British Columbia
-
Vancouver, British Columbia, Canada, V5Z 2G9
- Recruiting
- GF Strong Rehabilitation Hospital
-
Contact:
- Harvey Wu, MD
- Email: harvey.wu@ubc.ca
-
Principal Investigator:
- Michael Berger, MD, PhD
-
Sub-Investigator:
- Russell O'Connor, MD
-
Sub-Investigator:
- Erin Brown, MD
-
Sub-Investigator:
- Chris Doherty, MD
-
Sub-Investigator:
- Amy Hanlan, MD
-
-
Nova Scotia
-
Halifax, Nova Scotia, Canada, B3H 3A7
- Not yet recruiting
- QEII Health Sciences Centre
-
Contact:
- Emily Krauss
-
Principal Investigator:
- Emily Krauss, MD, MSc
-
-
Ontario
-
Kingston, Ontario, Canada, K7L 5G2
- Not yet recruiting
- Kingston Health Sciences Centre
-
Contact:
- Michael Hendry, MD, MSc
-
Principal Investigator:
- Michael Hendry, MD, MSc
-
Toronto, Ontario, Canada, M4N 3M5
- Not yet recruiting
- Sunnybrook Health Sciences Centre
-
Contact:
- Jana Dengler, MD, MASc
-
Principal Investigator:
- Jana Dengler, MD, MASc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Motor complete (AIS A or B) between neurological level of injury C5 and C8
- Able to provide informed written consent
- Able to attend and comply with the testing protocols
- Able to understand and speak English or have access to an appropriate interpreter as judged by the investigator.
Exclusion Criteria:
- An uncontrolled medical condition (e.g. uncontrolled cardiovascular disease, diabetes, kidney or liver disease)
- Have ever received botulinum toxin injections (Botox) for tone management in the upper limb
- An unmanaged secondary complication of SCI including but not limited to uncontrolled neuropathic pain or spasticity, syringomyelia, fracture, urinary tract infection or significant pressure ulcer, preventing participation in testing
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
---|
Experiemental: Surgical Arm
Individuals in this group will receive nerve transfer surgery 6 - 9 months post cervical spine injury and be observed for two years post-operatively.
|
Control: Non-surgical
Individuals in this group will not have undergone nerve transfer surgery.
They will be observed for two years post injury while receiving standard of care including medical and rehabilitation.
We want to reinforce that individuals are not being randomized to surgery versus non-surgery.
Rather individuals this group will either have made the decision not to undergo surgery, independent their participation in this study.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Graded Redefined Assessment of Strength, Sensibility and Prehension (GRASSP)
Time Frame: Baseline then every 3 months for 2 years
|
A validated upper limb functional measures and previously is used in SCI (Kalsi-Ryan et al. 2012) incorporates three domains vital to upper limb function: sensation, strength, and prehension.
|
Baseline then every 3 months for 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Modified Ashworth scores (MAS)
Time Frame: Baseline then every 3 months for 2 years
|
Modified Ashworth Scale (MAS) have been utilized in spinal cord injury patient population to assess spasticity by examining muscle tones.
|
Baseline then every 3 months for 2 years
|
Range of Motion
Time Frame: Baseline then every 3 months for 2 years
|
A Goniometer is used to measure range of motion of the joint angles (degrees) from the axis of the joint.
The measurement of joint movements is compared to its full potential.
|
Baseline then every 3 months for 2 years
|
Ultrasound
Time Frame: Baseline then every 3 months for 2 years
|
Ultrasound imaging to assess the structural health of recipient muscles and to quantify muscle fibrosis and atrophy.
|
Baseline then every 3 months for 2 years
|
Spinal Cord Independence Measure (SCIM)
Time Frame: Baseline then every 3 months for 2 years
|
The SCIM has been developed to address three specific areas of function in patients with spinal cord injuries such as activities of daily living, respiration and sphincter management, and a patient's mobility abilities.
|
Baseline then every 3 months for 2 years
|
Douleur Neuropathique 4 (DN-4)
Time Frame: Baseline then every 3 months for 2 years
|
A questionnaire consisting of 10 items and can be useful in assessment of neuropathic pain.
The items related to pain quality are based on an interview and examination of the patient.
|
Baseline then every 3 months for 2 years
|
Beck's Depression Inventory (BDI)
Time Frame: Baseline then every 3 months for 2 years
|
The questionnaire is a 21-item, self-report rating inventory that measures characteristic attitudes and symptoms of depression.
|
Baseline then every 3 months for 2 years
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michael Berger, MD, PHD, University of British Columbia
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Central Nervous System Diseases
- Nervous System Diseases
- Neurologic Manifestations
- Musculoskeletal Diseases
- Muscular Diseases
- Neuromuscular Manifestations
- Trauma, Nervous System
- Spinal Cord Diseases
- Muscle Weakness
- Wounds and Injuries
- Paralysis
- Spinal Cord Injuries
- Paresis
- Quadriplegia
Other Study ID Numbers
- H20-03350
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Upper Extremity Dysfunction
-
University of Texas at AustinCompletedUpper Extremity Dysfunction | Lower Extremity ProblemUnited States
-
Albert Schweitzer HospitalUnknownUpper Extremity DysfunctionNetherlands
-
University of Sao PauloUnknownUpper Extremity Dysfunction | Biomechanical Phenomena | Electromyography | Hand | Orthotic Devices
-
Vanderbilt University Medical CenterWithdrawnSexual Dysfunction | Upper Extremity Trauma
-
Seoul National University HospitalCompletedBrain Diseases | Upper Extremity DysfunctionKorea, Republic of
-
Bursa Yüksek İhtisas Education and Research HospitalNot yet recruitingHemiplegia | Upper Extremity Dysfunction
-
Hôpital du ValaisUniversity of Lausanne HospitalsCompleted
-
Hacettepe UniversityCompletedUpper Extremity InjuriesTurkey
-
Postgraduate Institute of Medical Education and...CompletedUpper Extremity Injury Trauma
-
Beijing Jishuitan HospitalCompletedUpper ExtremityChina